Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle-invasive bladder cancer

Asia-Pacific Journal of Clinical Oncology

Volumn 9, Issue 4, 2013, Pages 310-317

  Matsubara, Nobuaki ^a   Mukai, Hirofumi ^a   Naito, Yoichi ^a   Nezu, Masahiko ^a   Itoh, Kuniaki ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Adjuvant chemotherapy; Bladder cancer; Cisplatin; Gemcitabine; Neoadjuvant chemotherapy

Indexed keywords

CISPLATIN; GEMCITABINE; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE;

ADULT; AGED; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CHEMOSURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTECTOMY; DISEASE FREE SURVIVAL; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MALE; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; MUSCLE INVASIVE BLADDER CANCER; NEUTROPENIA; OUTCOME ASSESSMENT; PELVIS LYMPHADENECTOMY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; THROMBOCYTOPENIA; TREATMENT RESPONSE; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ANALOGS AND DERIVATIVES; MIDDLE AGED; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; TREATMENT OUTCOME; TUMOR INVASION; URINARY BLADDER NEOPLASMS;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; CYSTECTOMY; DEOXYCYTIDINE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 84888072821     PISSN: 17437555     EISSN: 17437563     Source Type: Journal    
DOI: 10.1111/ajco.12017     Document Type: Article

References (26)

1. Scher H, Bahnson R, Cohen S etal. NCCN urothelial cancer practice guidelines. National Comprehensive Cancer Network. Oncology (Huntingt) 1998; 12: 225-271.
2. Montie JE, Bahnson RR, Cohen SM etal. Bladder cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2005; 3: 4-5.
3. Ghoneim MA, el-Mekresh MM, el-Baz MA, el-Attar IA, Ashamallah A. Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1, 026 cases. J Urol 1997; 158: 393-399.
4. Stein JP, Lieskovsky G, Cote R etal. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1, 054 patients. J Clin Oncol 2001; 19: 666-675.
5. Grossman HB, Natale RB, Tangen CM etal. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 2003; 349: 859-866.
6. Logothetis CJ, Johnson DE, Chong C etal. Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update. J Clin Oncol 1988; 6: 1590-1596.
7. Sherif A, Holmberg L, Rintala E etal. Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studies. Eur Urol 2004; 45: 297-303.
8. Millikan R, Dinney C, Swanson D etal. Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC. J Clin Oncol 2001; 19: 4005-4013.
9. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists. Lancet 1999; 354: 533-540.
10. Martinez-Pineiro JA, Gonzalez Martin M, Arocena F etal. Neoadjuvant cisplatin chemotherapy before radical cystectomy in invasive transitional cell carcinoma of the bladder: a prospective randomized phase III study. J Urol 1995; 153: 964-973.
11. Malmstrom PU, Rintala E, Wahlqvist R, Hellstrom P, Hellsten S, Hannisdal E. Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group. J Urol 1996; 155: 1903-1906.
12. Sherif A, Rintala E, Mestad O etal. Neoadjuvant cisplatin-methotrexate chemotherapy for invasive bladder cancer: Nordic cystectomy Trial 2. Scand J Urol Nephrol 2002; 36: 419-425.
13. Wallace DM, Raghavan D, Kelly KA etal. Neo-adjuvant (pre-emptive) cisplatin therapy in invasive transitional cell carcinoma of the bladder. Br J Urol 1991; 67: 608-615.
14. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol 2005; 48: 202-205; discussion 205-6.
15. Advanced Bladder Cancer Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis. Lancet 2003; 361: 1927-1934.
16. Stockle M, Meyenburg W, Wellek S etal. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience. J Urol 1995; 153: 47-52.
17. Skinner DG, Daniels JR, Russell CA etal. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol 1991; 145: 459-464; discussion 464-7.
18. Svatek RS, Shariat SF, Lasky RE etal. The effectiveness of off-protocol adjuvant chemotherapy for patients with urothelial carcinoma of the urinary bladder. Clin Cancer Res 2010; 16: 4461-4467.
19. Mauri D, Pavlidis N, Ioannidis JP. Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis. J Natl Cancer Inst 2005; 97: 188-194.
20. Wosnitzer MS, Hruby GW, Murphy AM etal. A comparison of the outcomes of neoadjuvant and adjuvant chemotherapy for clinical T2-T4aN0-N2M0 bladder cancer. Cancer 2012; 118: 358-364.
21. Scosyrev E, Messing EM, van Wijngaarden E etal. Neoadjuvant gemcitabine and cisplatin chemotherapy for locally advanced urothelial cancer of the bladder. Cancer 2012; 118: 72-81.
22. Kaneko G, Kikuchi E, Matsumoto K etal. Neoadjuvant gemcitabine plus cisplatin for muscle-invasive bladder cancer. Jpn J Clin Oncol 2011; 41: 908-914.
23. von der Maase H, Hansen SW, Roberts JT etal. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol 2000; 18: 3068-3077.
24. Dash A, Pettus JA IV, Herr HW etal. A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience. Cancer 2008; 113: 2471-2477.
25. Weight CJ, Garcia JA, Hansel DE etal. Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder: a contemporary series. Cancer 2009; 115: 792-799.
26. David KA, Milowsky MI, Ritchey J, Carroll PR, Nanus DM. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base. J Urol 2007; 178: 451-454.